Skip to content
Stock screener

GRML Greenland Mines Ltd stock chart & analysis

Conviction 45HealthcareScan · Tue, Nov 10, 2026

Greenland Mines Ltd (GRML) closed at $3.98 (-4.56%) on Nov 10, 2026. Price is below its 50-day. RSI(14) 39, -81.9% from its 52-week high, -78.7% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

GRML$3.98-4.56%
ResistanceSupportVol 14Insider buyInsider sell
Loading chart…

Why GRML moved

From the StockSetups movers recaps that covered GRML, newest first. A recap states what was known that day.

  • Premarket+39.8%

    Greenland Mines is up 39.8% premarket to $7.68 on about 11.7 million shares versus a 20-day average of 25.2 million. Market cap is about $872.9 million, the largest of this group.

    Premarket Movers Oct 14, 2026: Why TGL, GLND, YRD Are Up →
  • Close+49.5%

    According to reporting from EBC Financial Group and multiple other outlets on September 21–22, GRML surged on the back of a U.S.-Denmark-Greenland security agreement that spotlighted Greenland's critical mineral resources.

    Top Stock Movers Sept 22, 2026: LHSW, RAIN, GRML →
  • Close+230.7%

    According to Yahoo Finance and Stocktwits, rare earth and Greenland-linked stocks soared across the board after President Trump unveiled what was described as a "permanent" US security deal for Greenland, cementing the island's strategic importance to the United States.

    Top Stock Movers Sept 21, 2026: GRML, GLND, BTTC →
  • Premarket+140.6%

    The same Trump US-Greenland security deal is driving GRML. Multiple outlets, including Seeking Alpha and Stocktwits, are citing the agreement as the catalyst for the Greenland-linked basket.

    Premarket Movers Sept 21, 2026: GLND, GRML, BTTC →
Greenland Mines LtdBiological Products, (No Diagnostic Substances)www.greenlandmines.com ↗
Price3.98
Change-4.56%
Gap-0.72%
Rel volume0.12×
Avg volume2.49M
Avg $ vol15.04M
SMA 205.18
SMA 506.19
SMA 200—
Price vs 50-35.66%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 5.90
RSI (14)39
MACD hist-0.08
MACD cross—
Stoch %K / %D17 / 16
ADX (14)16
+DI / −DI21 / 31
RSI divergence—
MACD divergenceBullish
ATR %20.56%
ADR %10.48%
52w high21.98
52w low2.82
From 52w high-81.90%
Above 52w low+41.13%
New 52w highNo
SqueezeOff
Bollinger width78.73%
%B0.21
Donchian pos11.03%
Donchian high7.53
Donchian low3.54
AVWAP (52w high)10.75
vs AVWAP high-62.96%
AVWAP (52w low)10.90
vs AVWAP low-63.48%
OBV trendUp
Chaikin MF (20)-0.45
Today vs 20d0.12×
Avg vol (14d)845.67K
Avg vol (20d)2.49M
Avg $ vol (20d)15.04M
Market cap632.23M
RS Rating—
RS 3m (vs SPY)-48.37%
RS 6m (vs SPY)-77.90%
RS line new highNo
Trend template—
Technical rank13.7
1 week-4.78%
1 month-33.89%
3 months-51.30%
6 months-76.31%
1 year—
YTD-78.74%
P/E-59.92
P/B10.92
P/S—
P/FCF—
EPS-0.2200
Div yield—
ROE-18.22%
ROA-16.23%
Debt/Eq0.01
Current10.09
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-71.56%
Price target—
Target upside—
Analyst rating—
Institutional3.17%
Ent. value623.23M
Revenue—
Net income-3.69M
Gross profit—
Free cash flow—
IndustryBiological Products, (No Diagnostic Substances)
ExchangeNasdaq
Shares out121.24M
Employees5
ListedThu, Mar 12, 2026
Free float100.83M
Float %83.2%
Short interest—
Days to cover—
Short volume47.3%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction45 / 100
Pattern quality—
Tech rank13.7 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.87
Support3.18
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

GRML technical analysis

Trend

It closed 35.7% below the 50-day ($6.19). ADX(14) at 16 points to a weak trend — more range than direction.

Momentum

RSI(14) is 39, in the bearish half of its range. The MACD histogram is negative. A bullish MACD divergence is in place.

Volume and volatility

Volume on the latest session ran 0.1× its 20-day average. It trades about $15.0M a day on average. ATR(14) is $0.8183, 20.6% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (-0.45) shows distribution.

Key levels

The chart pattern's support is $3.18 and its resistance $12.87. The 52-week range is $2.82 to $21.98; price is 81.9% below the high and 41.1% above the low. The VWAP anchored at the 52-week high is $10.75, above price.

Performance

GRML returned -4.8% (1 week), -33.9% (1 month), -51.3% (3 months), -76.3% (6 months), -78.7% (year to date).

About Greenland Mines Ltd

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Biological Products, (No Diagnostic Substances) · Listed 2026 · 5 employees

Insider activity

SEC Form 4 transactions in GRML · open-market 2 buys · 1 sell

InsiderSideShares
El-Dada Riad Hussein
Insider · Common Stock · 2026-10-01
Sell3.5K
LeBlanc Jeff
Chief Financial Officer · Common Stock · 2026-08-25
Buy14K
LeBlanc Jeff
Chief Financial Officer · Common Stock · 2026-07-16
Buy1.4M

SEC filings

EDGAR filings in GRML · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.